CardioComm Solutions, Inc.
EKGGF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.24 | -0.24 | 0.43 |
| FCF Yield | -9.59% | -6.91% | -2.25% | -0.61% |
| EV / EBITDA | -17.76 | -339.57 | 26.39 | -81.45 |
| Quality | ||||
| ROIC | -101.38% | -140.04% | -346.11% | -65.88% |
| Gross Margin | 76.61% | 93.61% | 91.42% | 99.65% |
| Cash Conversion Ratio | 0.64 | 1.44 | 5.40 | 0.50 |
| Growth | ||||
| Revenue 3-Year CAGR | -25.61% | -16.60% | -18.14% | -19.13% |
| Free Cash Flow Growth | -82.92% | -91.80% | -215.40% | 74.17% |
| Safety | ||||
| Net Debt / EBITDA | -3.73 | -62.03 | 2.31 | -4.89 |
| Interest Coverage | -15.17 | -14.43 | -0.48 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.63 | 0.24 | 0.54 | 0.01 |
| Cash Conversion Cycle | 126.45 | -322.37 | -3.72 | -2,726.47 |